News
PBM
3.350
-1.47%
-0.050
Weekly Report: what happened at PBM last week (0803-0807)?
Weekly Report · 2d ago
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update
TipRanks · 6d ago
Weekly Report: what happened at PBM last week (0727-0731)?
Weekly Report · 08/03 10:19
Weekly Report: what happened at PBM last week (0720-0724)?
Weekly Report · 07/27 10:23
Weekly Report: what happened at PBM last week (0713-0717)?
Weekly Report · 07/20 10:19
Weekly Report: what happened at PBM last week (0706-0710)?
Weekly Report · 07/13 10:21
Weekly Report: what happened at PBM last week (0629-0703)?
Weekly Report · 07/06 10:25
Weekly Report: what happened at PBM last week (0622-0626)?
Weekly Report · 06/29 10:20
Weekly Report: what happened at PBM last week (0615-0619)?
Weekly Report · 06/22 10:29
Weekly Report: what happened at PBM last week (0608-0612)?
Weekly Report · 06/15 10:30
Weekly Report: what happened at PBM last week (0601-0605)?
Weekly Report · 06/08 10:25
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan
TipRanks · 06/05 21:26
Weekly Report: what happened at PBM last week (0525-0529)?
Weekly Report · 06/01 10:31
Weekly Report: what happened at PBM last week (0518-0522)?
Weekly Report · 05/25 10:34
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 05/19 17:06
Weekly Report: what happened at PBM last week (0511-0515)?
Weekly Report · 05/18 10:34
Psyence Biomedical announces U.S. engagement initiative focused on ibogaine
TipRanks · 05/15 14:51
Psyence BioMed Establishes Active Ibogaine Operations, Production Capabilities In Africa
Benzinga · 05/15 13:18
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 05/13 21:06
Prestige Consumer Healthcare Announces agreement To Acquire LaCorium Health, A Leader In Australian Therapeutic Skin Care For ~150M
Benzinga · 05/13 20:33
More
Webull provides a variety of real-time PBM stock news. You can receive the latest news about Psyence Biomedical Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.